Oral Pharmaceutical Product Packaging – An Enhanced Quality-Based Approach of Performance Evaluation

A critical aspect of drug delivery that ensures the product's safety, efficacy, and compliance with regulations is Pharmaceutical Packaging (PhP). In this process, the packaging material choice mostly relies on factors like the drug's characteristics, required level of protection, and cost. Prior studies regarding the packaging materials, market movement, and quality deficiency studies were limited, though the significance of packaging was well-known. Therefore, analysing the quality-based approach for the packaging of oral pharmaceuticals is the main aim of the present study. The present study adopts a mixed method and collects data from primary and secondary sources. 100 eligible participants (n=20 material converters, n=80 end-consumers) are selected for the study utilizing a purposive sampling method and a standardised questionnaire. In the study outcomes, an enhanced market movement and market preference (50%) of flexible materials in various industries was proven. It also verified that the products’ quality was highly influenced by the packaging defects (44%). Furthermore, the preference for flexible materials and their potential demand in future packaging industries was highlighted in the present findings.